Symbolbild · KI-generiert
Neural Therapeutics Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. On May 26, 2025, Neural entered into a Strategic Investment and Option Agreement with CWE European Holdings Inc., a leading CBD hemp retailer in Germany operating under the brand Hanf.com, to acquire up to 100% of CWE through a multi-stage transaction. On August 13, 2025, Neural completed the first stage of this transaction, acquiring a 30.75% equity interest in CWE. The investment provides Neural with exposure to Hanf.com’s established retail and eCommerce operations, which include 15 stores in Germany (11 directly owned and 4 franchises) and a growing product portfolio. The transaction is expected to expand Neural’s commercial footprint in Europe while maintaining its core commitment to drug discovery and mental health innovation.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Neural Therapeutics Inc. | NURL | CSE | 2 Mio. USD |
| Fountain Asset Corp. | FA | TSXV | 2 Mio. USD |
| Rakovina Therapeutics Inc. | RKV | TSXV | 2 Mio. USD |
| Zero Candida Technologies Inc. | ZCT | TSXV | 2 Mio. USD |
| Therma Bright Inc. | THRM | TSXV | 2 Mio. USD |
| Appili Therapeutics Inc. | APLI | TSX | 1 Mio. USD |
| CardioComm Solutions Inc. | EKG | TSXV | 1 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.